Colonoscopy Clinical Trials

Clinical trials related to Colonoscopy Procedure

An Observational Study to Examine Non-inferiority of the Standard ASA Fasting Guidelines Versus 24-hour Clear Liquid Diet for Gastric Volume in Patients Taking GLP-1 Agonists

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study will enroll patients 18 years and older who are taking a GLP-1/GIP medication and 1) are scheduled for elective surgery and meet ASA fasting guidelines (nothing by mouth for at least 8 hours prior), or 2) scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior. Participants will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The purpose of this study is to determine if people taking GLP-1 receptor agonists and who fast normally are at an equal risk for having retained gastric contents after appropriately fasting for surgery, compared to patients who are on a liquid only diet for 24 hours prior to surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18+

• Have taken a GLP-1 or GLP-GIP agonist medication within the past 30 days

• ASA Physical Classification Status 1-3

• Fall into one of the following groups:

‣ Scheduled elective surgery and meet ASA fasting guidelines (NPO for at least 8 hours prior)

⁃ Scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior

Locations
United States
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Contact Information
Primary
Haley Nitchie, MHA
nitchie@musc.edu
843-792-1869
Time Frame
Start Date: 2026-02-03
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 150
Treatments
ASA fasting guidelines
Scheduled elective surgery and meet ASA fasting guidelines (NPO for at least 8 hours prior)
24-hour clear liquid diet
Scheduled elective colonoscopy and have been on a clear liquid diet for at least 24 hours prior
Related Therapeutic Areas
Sponsors
Leads: Medical University of South Carolina

This content was sourced from clinicaltrials.gov